176 related articles for article (PubMed ID: 27862305)
41. Immunohistochemical study of MUC1 mucin in premalignant oral lesions and oral squamous cell carcinoma: association with disease progression, mode of invasion, and lymph node metastasis.
Nitta T; Sugihara K; Tsuyama S; Murata F
Cancer; 2000 Jan; 88(2):245-54. PubMed ID: 10640953
[TBL] [Abstract][Full Text] [Related]
42. Association of Notch4 with metastasis in human oral squamous cell carcinoma.
Mk H; Prince S; Mohan AM; Krishnan KV; Devi A
Life Sci; 2016 Jul; 156():38-46. PubMed ID: 27197026
[TBL] [Abstract][Full Text] [Related]
43. Silencing profilin-1 inhibits gastric cancer progression via integrin β1/focal adhesion kinase pathway modulation.
Cheng YJ; Zhu ZX; Zhou JS; Hu ZQ; Zhang JP; Cai QP; Wang LH
World J Gastroenterol; 2015 Feb; 21(8):2323-35. PubMed ID: 25741138
[TBL] [Abstract][Full Text] [Related]
44. RNAi-mediated down-regulation of alpha-actinin-4 decreases invasion potential in oral squamous cell carcinoma.
Yamada S; Yanamoto S; Yoshida H; Yoshitomi I; Kawasaki G; Mizuno A; Nemoto TK
Int J Oral Maxillofac Surg; 2010 Jan; 39(1):61-7. PubMed ID: 19913389
[TBL] [Abstract][Full Text] [Related]
45. Down-regulation of keratin 4 and keratin 13 expression in oral squamous cell carcinoma and epithelial dysplasia: a clue for histopathogenesis.
Sakamoto K; Aragaki T; Morita K; Kawachi H; Kayamori K; Nakanishi S; Omura K; Miki Y; Okada N; Katsube K; Takizawa T; Yamaguchi A
Histopathology; 2011 Mar; 58(4):531-42. PubMed ID: 21371075
[TBL] [Abstract][Full Text] [Related]
46. Activation of MAP kinase signaling through ERK5 but not ERK1 expression is associated with lymph node metastases in oral squamous cell carcinoma (OSCC).
Sticht C; Freier K; Knöpfle K; Flechtenmacher C; Pungs S; Hofele C; Hahn M; Joos S; Lichter P
Neoplasia; 2008 May; 10(5):462-70. PubMed ID: 18472963
[TBL] [Abstract][Full Text] [Related]
47. The methylation status and expression of human telomerase reverse transcriptase is significantly high in oral carcinogenesis.
Haraguchi K; Yada N; Sato S; Habu M; Hayakawa M; Takahashi O; Sasaguri M; Takenaka S; Yoshioka I; Matsuo K; Tominaga K
APMIS; 2017 Sep; 125(9):797-807. PubMed ID: 28766760
[TBL] [Abstract][Full Text] [Related]
48. Copy number amplification of 3q26-27 oncogenes in microdissected oral squamous cell carcinoma and oral brushed samples from areca chewers.
Lin SC; Liu CJ; Ko SY; Chang HC; Liu TY; Chang KW
J Pathol; 2005 Aug; 206(4):417-22. PubMed ID: 15906274
[TBL] [Abstract][Full Text] [Related]
49. Cyclin D1 expression and its possible regulation in chewing tobacco mediated oral squamous cell carcinoma progression.
Mishra R; Das BR
Arch Oral Biol; 2009 Oct; 54(10):917-23. PubMed ID: 19679297
[TBL] [Abstract][Full Text] [Related]
50. Stage and mRNA expression of survivin in lymph node as prognostic indicators in patients with oral squamous cell carcinoma.
Kim MJ; Lim KY; Kim JW; Nam IW; Lee JH; Myoung H
Cancer Lett; 2005 Jun; 224(2):253-61. PubMed ID: 15914276
[TBL] [Abstract][Full Text] [Related]
51. Dual role of CCL3/CCR1 in oral squamous cell carcinoma: implications in tumor metastasis and local host defense.
Silva TA; Ribeiro FL; Oliveira-Neto HH; Watanabe S; Alencar Rde C; Fukada SY; Cunha FQ; Leles CR; Mendonça EF; Batista AC
Oncol Rep; 2007 Nov; 18(5):1107-13. PubMed ID: 17914560
[TBL] [Abstract][Full Text] [Related]
52. Decreased expression of Ep-CAM protein is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan.
Hwang EY; Yu CH; Cheng SJ; Chang JY; Chen HM; Chiang CP
J Oral Pathol Med; 2009 Jan; 38(1):87-93. PubMed ID: 18355175
[TBL] [Abstract][Full Text] [Related]
53. A comparative analysis of langerhans cell in oral epithelial dysplasia and oral squamous cell carcinoma using antibody CD-1a.
Upadhyay J; Rao NN; Upadhyay RB
J Cancer Res Ther; 2012; 8(4):591-7. PubMed ID: 23361280
[TBL] [Abstract][Full Text] [Related]
54. [Expression of MMP1 mRNA in oral squamous cell carcinoma and paired normal tissues].
Lü XZ; Zou YG; Yin XM; Chen WT; Zhang CP
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(8):1362-4. PubMed ID: 18753061
[TBL] [Abstract][Full Text] [Related]
55. GLI-mediated Keratin 17 expression promotes tumor cell growth through the anti-apoptotic function in oral squamous cell carcinomas.
Mikami Y; Fujii S; Nagata K; Wada H; Hasegawa K; Abe M; Yoshimoto RU; Kawano S; Nakamura S; Kiyoshima T
J Cancer Res Clin Oncol; 2017 Aug; 143(8):1381-1393. PubMed ID: 28342001
[TBL] [Abstract][Full Text] [Related]
56. Expression of hepatocyte growth factor and c-met protein is significantly associated with the progression of oral squamous cell carcinoma in Taiwan.
Chen YS; Wang JT; Chang YF; Liu BY; Wang YP; Sun A; Chiang CP
J Oral Pathol Med; 2004 Apr; 33(4):209-17. PubMed ID: 15061708
[TBL] [Abstract][Full Text] [Related]
57. The expression of EMP1 is downregulated in oral squamous cell carcinoma and possibly associated with tumour metastasis.
Zhang J; Cao W; Xu Q; Chen WT
J Clin Pathol; 2011 Jan; 64(1):25-9. PubMed ID: 20980531
[TBL] [Abstract][Full Text] [Related]
58. [P53 expression and clinical significance in oral squamous cell carcinoma].
Long Y; Ling D; Yue W
Hua Xi Kou Qiang Yi Xue Za Zhi; 1997 May; 15(2):115-6, 122. PubMed ID: 11480024
[TBL] [Abstract][Full Text] [Related]
59. Differential Expression of Cytokeratin 13 in Non-Neoplastic, Dysplastic and Neoplastic Oral Mucosa in a High Risk Pakistani Population.
Farrukh S; Syed S; Pervez S
Asian Pac J Cancer Prev; 2015; 16(13):5489-92. PubMed ID: 26225699
[TBL] [Abstract][Full Text] [Related]
60. Fos-related activator-1 is overexpressed in oral squamous cell carcinoma and associated with tumor lymph node metastasis.
Zhang L; Pan HY; Zhong LP; Wei KJ; Yang X; Li J; Shen GF; Zhang Z
J Oral Pathol Med; 2010 Jul; 39(6):470-6. PubMed ID: 20149058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
